Fagron N.V. | |
Stock Exchange | Euronext Brussels |
EPS |
EUR0.59 |
Market Cap |
EUR1.17 B |
Shares Outstanding |
71.84 M |
Public Float |
36.19 M |
Fagron N.V. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
71.84 M |
Public Float |
- |
Address |
Venecoweg 20A Nazareth VL 9810 Belgium |
Employees | - |
Website | http://www.fagron.com |
Updated | 07/08/2019 |
Fagron NV engages in the provision of development, marketing, and distribution of healthcare products and services. It operates through the following segments: Fagron Specialty Pharma Services (FSPS); Fagron Trademarks (FTM); Fagron Essentials (FE); and HL Technology. The FSPS segment refers to all personalized medication that is prepared in sterile and non-sterile compounding facilities in Europe, the United States, Colombia and South Africa. |